Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Greenwood. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Greenwood at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with NMIBC CIS (with or without resected papillary disease (Ta, T1)) that are considered Bacillus Calmette-Guerin ("BCG")-Unresponsive or who are intolerant to BCG therapy. BCG-Unresponsive is at least one of the following: At least five of six doses of an initial induction course plus at least two of three doses of maintenance therapy; or, at least five of six doses of an initial i
Sponsor: Theralase® Technologies Inc.
Check if you qualify for this bladder cancer clinical trial in Greenwood, IN
If you're searching for bladder cancer treatment options in Greenwood, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Greenwood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.